Key Takeaways:
- 1. US groups specializing in drug chemistry are collaborating with researchers in Germany to develop potential drugs for pediatric cancer.
- 2. Funding from NIH is confirmed for the project, but researchers are concerned about the future beyond the current financial year.
- 3. International collaboration is crucial in the field of rare diseases, as no single country has the necessary resources or patient numbers.
Researchers in the US and Germany are working together to develop potential drugs for pediatric cancer, with funding confirmed for the current year but uncertainty beyond that. Collaboration is essential due to the lack of resources and patient numbers in any single country. While Europe has pledged to fill the funding gap left by the US, the amounts discussed are insufficient and may impact critical collaborations.
Insight: Collaboration between countries is crucial for advancing research in rare diseases, as no single country has the resources or patient numbers required for effective clinical trials.
This article was curated by memoment.jp from the feed source: Ars Technica.
Read the original article here: https://arstechnica.com/science/2025/06/nih-budget-cuts-affect-research-funding-beyond-us-borders/
© All rights belong to the original publisher.
